N8 Medical to Split Medical Device and Pharmaceutical Businesses COLUMBUS, Ohio, June 5, 2015 (GLOBE NEWSWIRE) -- N8 Medical, an emerging pharmaceutical company addressing life-threatening global health challenges through the development of high-value...

Recently Published Study Demonstrates That CSA-90 May Promote Osteogenesis and Prevent Staphylococcus aureus Infection in Preclinical Models COLUMBUS, Ohio, March 4, 2015 (GLOBE NEWSWIRE) -- N8 Medical, an emerging pharmaceutical company addressing life-threatening global health challenges through the development of high-value...

Recently Published Reviews Highlight the Potential Utility of Ceragenins in the Fight Against Biofilm Mediated and Multidrug Resistant Bacterial Infections COLUMBUS, Ohio, Dec. 1, 2014 (GLOBE NEWSWIRE) -- N8 Medical, an emerging pharmaceutical company addressing life-threatening global health challenges through the development of high-value...

N8 Respiratory Presents Data Demonstrating Antimicrobial Efficacy of CSA-13 Against Psuedomonas Aeruginosa Biofilm COLUMBUS, Ohio, Oct. 9, 2014 (GLOBE NEWSWIRE) -- N8 Respiratory, LLC., (a subsidiary of N8 Medical, Inc.) an emerging respiratory therapeutics company focused on the development of ceragenins as...

N8 Respiratory Hires Industry Leader as Chief Operating Officer COLUMBUS, Ohio, June 23, 2014 (GLOBE NEWSWIRE) -- N8 Respiratory, LLC., a subsidiary of N8 Medical, Inc., an emerging pharmaceutical company focused on developing anti-infective therapies for...